Hepatotoxicity during Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living with HIV with Severe Immunosuppression: a Secondary Analysis of a Multi-country Open-label Randomized Controlled Clinical Trial.
about
Hepatotoxicity during Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living with HIV with Severe Immunosuppression: a Secondary Analysis of a Multi-country Open-label Randomized Controlled Clinical Trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Hepatotoxicity during Isoniazi ...... zed Controlled Clinical Trial.
@en
Hepatotoxicity during Isoniazi ...... zed Controlled Clinical Trial.
@nl
type
label
Hepatotoxicity during Isoniazi ...... zed Controlled Clinical Trial.
@en
Hepatotoxicity during Isoniazi ...... zed Controlled Clinical Trial.
@nl
prefLabel
Hepatotoxicity during Isoniazi ...... zed Controlled Clinical Trial.
@en
Hepatotoxicity during Isoniazi ...... zed Controlled Clinical Trial.
@nl
P2093
P2860
P1476
Hepatotoxicity During Isoniazi ...... ized Controlled Clinical Trial
@en
P2093
AIDS Clinical Trials Group A5274 (REMEMBER) Study Team
Amita Gupta
Jeffrey A Lavenberg
Johnstone Kumwenda
Katende Kenneth Kidonge
McNeil Ngongondo
Michael D Hughes
Mina C Hosseinipour
Sachiko Miyahara
Thiago Silva Torres
P2860
P356
10.1097/QAI.0000000000001641
P407
P577
2018-05-01T00:00:00Z